Guiding a docking mode by phage display: Selection of correlated mutations at the staphylokinase-plasmin interface

Journal of Molecular Biology

Volumn 290, Issue 2, 1999, Pages 471-479

  Jespers, Laurent ^a   Lijnen, H Roger ^b   Vanwetswinkel, Sophie ^a   Van Hoef, Berthe ^b   Brepoels, Katleen ^a   Collen, Désiré ^a,b   De Maeyer, Marc ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Correlated mutations; Dead end elimination; Phage display; Plasminogen activation; Staphylokinase

Indexed keywords

ARGININE; GLUTAMIC ACID; GLYCINE; LYSINE; PLASMIN; STAPHYLOKINASE; VALINE;

ARTICLE; GEOMETRY; MUTATION; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

UNIDENTIFIED BACTERIOPHAGE;

EID: 0033538423     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.2887     Document Type: Article

References (35)

1. Atwell S., Ultsch M., De Vos A. M., Wells J. A. Structural plasticity in a remodeled protein-protein interface. Science. 278:1997;1125-1128.
2. Bogan A. A., Thorn K. S. Anatomy of hot spots in protein interfaces. J. Mol. Biol. 280:1998;1-9.
3. Carter P. J., Winter G., Wilkinson A. J., Fersht A. R. The use of double-mutants to detect structural changes in the active site of the tyrosyl-tRNA synthetase (Bacillus stearothermophilus). Cell. 38:1984;835-840.
4. Clackson T., Wells J. A. A hot spot of binding energy in a hormone-receptor interface. Science. 267:1995;383-386.
5. Claessens M., Van Cutsem E., Lasters I., Wodak S. Modeling the polypeptide backbone with "spare parts" from known protein structures. Protein Eng. 2:1989;335-345.
6. Collen D., Lijnen H. R. Staphylokinase, a fibrin-specific plasminogen activator with therapeutic potential? Blood. 84:1994;680-686.
7. Cunningham B. C., Wells J. A. Comparison of a structural and a functional epitope. J. Mol. Biol. 234:1993;554-563.
8. Desmet J., De Maeyer M., Hazes B., Lasters I. The dead-end elimination theorem and its use in protein side-chain positioning. Nature. 356:1992;539-542.
9. Horowitz A. Non-additivity in protein-protein interactions. J. Mol. Biol. 224:1987;733-740.
10. Horton R. M., Hunt H. D., Ho S. N., Pullen J. K., Pease L. R. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene. 77:1989;61-68.
11. Hwang J.-K., Warshel A. Why ion pair reversal by protein engineering is unlikely to succeed. Nature. 334:1988;270-272.
12. Jenné S., Brepoels K., Collen D., Jespers L. High resolution mapping of the B cell epitopes of staphylokinase in humans using negative selection of a phage-displayed antigen library. J. Immunol. 161:1998;3161-3168.
13. Jespers L., Jenné S., Lasters I., Collen D. Epitope mapping by negative selection of randomized antigen libraries displayed on filamentous phage. J. Mol. Biol. 269:1997;704-718.
14. Jespers L., Van Herzeele N., Lijnen H. R., Van Hoef B., De Maeyer M., Collen D., Lasters I. Arginine 719 in human plasminogen mediates formation of the staphylokinase:plasmin activator complex. Biochemistry. 37:1998;6380-6386.
15. Jin L., Fendly B. M., Wells J. A. High resolution functional analysis of antibody-antigen interactions. J. Mol. Biol. 226:1992;851-865.
16. Jucovic M., Hartley R. W. Protein-protein interaction: a genetic selection for compensating mutations at the barnase-barstar interface. Proc. Natl Acad. Sci. USA. 93:1996;2343-2347.
17. Korasi R., Billeter M., Wuthrich K. MolMol: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14:1996;51-55.
18. Lamba D., Bauer M., Huber R., Fischer S., Rudolph R., Kohnert U., Bode W. The 2.3 Å crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator. J. Mol. Biol. 258:1996;117-135.
19. Lengauer T., Rarey M. Computational methods for biomolecular docking. Curr. Opin. Struct. Biol. 6:1996;402-406.
20. Lijnen H. R., Van Hoef B., Nelles L., Collen D. Plasminogen activation with single-chain urokinase-type plasminogen activator (scu-PA). Studies with active site mutagenized plasminogen (Ser740Ala) and plasmin-resistant scu-PA (Lys158Glu). J. Biol. Chem. 265:1990;5232-5236.
21. Lijnen H. R., Van Hoef B., De Cock F., Okada K., Ueshima S., Matsuo O., Collen D. On the mechanism of fibrin-specific plasminogen activation by staphylokinase. J. Biol. Chem. 266:1991;11826-11832.
22. Lijnen H. R., De Cock F., Van Hoef B., Schlott B., Collen D. Characterization of the interaction between plasminogen and staphylokinase. Eur. J. Biochem. 224:1994;143-149.
23. Lijnen H. R., Lasters I., Verstreken M., Collen D., Jespers L. Screening panels of monoclonal antibodies using phage-displayed antigen. Anal. Biochem. 248:1997;211-215.
24. Lowman H. B. Phage display of peptide libraries on protein scaffolds. Cabilly S. Methods in Molecular Biology: Combinatorial Peptide Library Protocols. 1998;249-264 Humana Press, Totowa, NJ.
25. Madison E. L., Goldsmith E. J., Gething M. J., Sambrook J. F., Gerard R. D. Restoration of serine protease inhibitor interaction by protein engineering. J. Biol. Chem. 265:1990;21423-21426.
26. Muller Y. A., Chen Y., Christinger H. W., Li B., Cunningham B., Lowman H. B., de Vos A. M. VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 Å resolution and mutational analysis of the interface. Structure. 6:1998;1153-1167.
27. Parry M. A. A., Fernandez-Catala C., Bergner A., Huber R., Hopfner K. P., Schlott B., Gührs K. H., Bode W. The ternary microplasmin- staphylokinase-microplasmin complex is a proteinase-cofactor-substrate complex in action. Nature Struct. Biol. 5:1998;917-923.
28. Pearce K. H., Ultsch M. H., Kelley R. F., De Vos A. M., Wells J. A. Structural and functional analysis of affinity-inert contact residues at the growth hormone-receptor interface. Biochemistry. 35:1996;10300-10307.
29. Rabijns A., De Bondt H., De Ranter C. Three-dimensional structure of staphylokinase, a plasminogen activator with therapeutic potential. Nature Struct. Biol. 4:1997;357-360.
30. Schlott B., Hartmann M., Gührs E., Birch-Hirschfeld H., Pohl S., Vanderschueren S., Van de Werf F., Michoel A., Collen D., Behnke D. High yield production and purification of recombinant staphylokinase for thrombolytic therapy. Biotechnology. 12:1994;185-189.
31. Schreiber G., Fersht A. Energetics of protein-protein interactions: analysis of the barnase-barstar interface by single mutations and double-mutant cycles. J. Mol. Biol. 248:1995;478-486.
32. Scopes R. K. Measurement of protein by spectrophotometry at 205 nm. Anal. Biochem. 59:1974;277-282.
33. Silence K., Collen D., Lijnen H. R. Interaction between staphylokinase, plasmin(ogen), and alpha 2-antiplasmin. Recycling staphylokinase after neutralization of the plasmin-staphylokinase complex by alpha 2-antiplasmin. J. Biol. Chem. 268:1993;9811-9816.
34. Silence K., Hartmann M., Gührs K. H., Gase A., Schlott B., Collen D., Lijnen H. R. Structure-function relationships in staphylokinase revealed by "clustered charge to alanine" mutagenesis. J. Biol. Chem. 270:1995;27192-27198.
35. Wells J. A. Systematic mutational analyses of protein-protein interfaces. Methods Enzymol. 202:1991;390-411.